158 related articles for article (PubMed ID: 20943201)
1. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.
Bantia S; Kellogg D; Parker CD; Babu YS
Antiviral Res; 2010 Dec; 88(3):276-80. PubMed ID: 20943201
[TBL] [Abstract][Full Text] [Related]
2. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice.
Galabov AS; Simeonova L; Gegova G
Antivir Chem Chemother; 2006; 17(5):251-8. PubMed ID: 17176629
[TBL] [Abstract][Full Text] [Related]
3. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.
Simeonova L; Gegova G; Galabov AS
Antiviral Res; 2012 Aug; 95(2):172-81. PubMed ID: 22617756
[TBL] [Abstract][Full Text] [Related]
5. Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
Bantia S; Arnold CS; Parker CD; Upshaw R; Chand P
Antiviral Res; 2006 Jan; 69(1):39-45. PubMed ID: 16325932
[TBL] [Abstract][Full Text] [Related]
6. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells.
Govorkova EA; Fang HB; Tan M; Webster RG
Antimicrob Agents Chemother; 2004 Dec; 48(12):4855-63. PubMed ID: 15561867
[TBL] [Abstract][Full Text] [Related]
9. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
10. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.
Farooqui A; Huang L; Wu S; Cai Y; Su M; Lin P; Chen W; Fang X; Zhang L; Liu Y; Zeng T; Paquette SG; Khan A; Kelvin AA; Kelvin DJ
Antimicrob Agents Chemother; 2015 Dec; 59(12):7255-64. PubMed ID: 26369969
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.
Mishin VP; Hayden FG; Signorelli KL; Gubareva LV
Antiviral Res; 2006 Aug; 71(1):64-8. PubMed ID: 16581141
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.
Li Z; Li R; Li J; Xie H; Hao Y; Du Q; Chen T; Li Y; Chen R; Yang Z; Zhong N
BMC Infect Dis; 2016 Jul; 16():325. PubMed ID: 27392915
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing.
Drusano GL; Preston SL; Smee D; Bush K; Bailey K; Sidwell RW
Antimicrob Agents Chemother; 2001 Jul; 45(7):2115-8. PubMed ID: 11408232
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza.
Yamanaka T; Bannai H; Nemoto M; Tsujimura K; Kondo T; Muranaka M; Hobo S; Minamijima YH; Yamada M; Matsumura T
Vet J; 2012 Aug; 193(2):358-62. PubMed ID: 22326934
[TBL] [Abstract][Full Text] [Related]
16. Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Jang SI; Kim H; Cheong HJ; Song JW; Song KJ; Baek LJ; Park MS
PLoS One; 2014; 9(7):e101325. PubMed ID: 24992479
[TBL] [Abstract][Full Text] [Related]
17. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
Tarbet EB; Maekawa M; Furuta Y; Babu YS; Morrey JD; Smee DF
Antiviral Res; 2012 Apr; 94(1):103-10. PubMed ID: 22429564
[TBL] [Abstract][Full Text] [Related]
18. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
Nau JY
Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
[No Abstract] [Full Text] [Related]
19. Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.
Abed Y; Simon P; Boivin G
Antimicrob Agents Chemother; 2010 Jul; 54(7):2819-22. PubMed ID: 20404128
[TBL] [Abstract][Full Text] [Related]
20. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
Atiee G; Lasseter K; Baughman S; McCullough A; Collis P; Hollister A; Hernandez J
J Clin Pharmacol; 2012 Sep; 52(9):1410-9. PubMed ID: 21960669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
